PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.

Create a free account to list your company for free!

We are 5000 highly trained healthcare professionals and support staff across the UK, Australia, Spain and the US, designing innovative treatments and care for people with every type of cancer. We believe care should be focused on you, the individual, not the condition.
Genialis is a computational precision medicines company unravelling complex biology to find new ways to address disease. ResponderID™, Genialis’ clinical biomarker discovery platform, defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development.
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.
We deliver the understanding of the genomic drivers of every disease for Pharma. Our curated Genomic Landscapes provide immediate insight into the genomic evidence for every phenotype, disease, gene, and variant.
Genomics plc is a leading genome analysis company formed in 2014 by four leading scientists at the University of Oxford.
Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services.
We’re committed to creating possible. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.
An Independent Research Organisation. We are engaged in National and International research studies that seek to find better treatments for those with Memory Impairment, Alzheimer’s disease and Dementia. We have a range of studies running at the clinic suitable for those with varying degrees of Memory Impairment, Alzheimer’s disease and Dementia.
A full service CRO in the USA, Europe and Asia providing global coverage and local expertise for biotech, pharma and medical device companies since 2001. We offer a tailored approach to each project and client with end-to-end support for Phase I-V studies following the latest ICH-GCP, EMA, and FDA guidelines and local regulations.
Global Pharma Tek is one of the leading providers of specialized clinical research services tailored to assist biotechnology, pharmaceutical, and medical device companies in efficiently bringing new drugs and devices to global markets.
GlycoMimetics is a hematology-oncology focused biotechnology company. We are dedicated to improving the lives of patients by discovering, developing and commercializing novel, small-molecule glycomimetic product candidates.
GovGrant helps pharmaceutical firms who undertake research & development reduce their expenses by claiming tax credits through HMRC schemes.
At Graphite Bio, we are rapidly building a next-generation gene editing company that is driven to apply our groundbreaking technology with urgency to advance gene replacement therapies and cures for people living with serious diseases. We stand apart through our ability to harness natural and highly precise cellular DNA repair machinery to achieve high efficiency, targeted gene integration to correct the underlying causes of diseases.